WEDNESDAY 23 JANUARY 2002
in the Chair
|Mr David Amess||Sandra Gidley
|Andy Burnham||Siobhain McDonagh
|Mr Simon Burns||Dr Doug Naysmith
|Jim Dowd||Dr Richard Taylor
The Committee deliberated.
National Institute for Clinical Excellence: Dr Tim Crayford,
Deputy Director of Public Health and Chairman, Prescribing Committee,
and Helen Marlow, Pharmaceutical Adviser, Croydon Health Authority,
Dr Deirdre Cunningham, Director of Public Health and Health Systems,
Lambeth, Southwark and Lewisham Health Authority, and Mr David
Walker, Director of Public Health, Newcastle and North Tyneside
Health Authority, were examined.
Mr Eddie Gray, General Manager and Senior Vice-President,
GlaxoSmithKline, Mr Hugh McKinney, Director, and Mr David Campbell-Morrison,
Director, Campaign for Effective and Rational Treatment, Dr Trevor
Jones, Director General, Mr Edgar Fullagar, President, and Dr
John Patterson, President-elect, Association of the British Pharmaceutical
Industry, were examined.
[Adjourned till Thursday 24 January at half-past Ten.